PIM
Ponoi II Management Portfolio holdings
AUM
$38.3M
This Quarter Return
+40.81%
1 Year Return
-32.02%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$137M
AUM Growth
–
Cap. Flow
+$137M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$45.3M |
| 2 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$39.4M |
| 3 |
Revolution Medicines
RVMD
|
$27.1M |
| 4 |
Nurix Therapeutics
NRIX
|
$22.6M |
| 5 |
RAPT Therapeutics
RAPT
|
$2.87M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $45.3M | 33.03% |
+1,574,229
| New | +$45.3M |
|
|
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $39.4M | 28.68% |
+1,298,908
| New | +$39.4M |
|
|
3
Revolution Medicines
RVMD
$7.1B
| $27.1M | 19.76% |
+685,011
| New | +$27.1M |
|
|
4
Nurix Therapeutics
NRIX
$714M
| $22.6M | 16.44% |
+686,274
| New | +$22.6M |
|
|
5
RAPT Therapeutics
RAPT
$188M
| $2.87M | 2.09% |
+145,401
| New | +$2.87M |
|